The Safety and Accuracy of Drug Patch Testing in Delayed Hypersensitivity Reactions

被引:0
作者
Saff, Rebecca R. [1 ,2 ]
Waldron, Jamie L. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, 55 Fruit St,Yawkey 4B, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
关键词
Adverse drug reaction; Drug allergy; Drug hypersensitivity; Severe cutaneous adverse reaction; Skin testing; Patch testing; EXANTHEMATOUS PUSTULOSIS AGEP; STEVENS-JOHNSON SYNDROME; ADVERSE-REACTIONS; SYSTEMIC REACTIONS; SKIN-TESTS; DIAGNOSIS; ERUPTIONS; ALLERGY; ALLOPURINOL; MULTICENTER;
D O I
10.1007/s13671-023-00405-9
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Purpose of ReviewAdverse drug reactions are common in both the inpatient and outpatient settings and lead to limitations in future treatment options. Patch testing, used in conjunction with clinical history and the reaction phenotype, can help to improve identification of the culprit medication and evidence for its use is growing. Here we discuss a standardized approach to patch testing which can lead to accurate and reproducible results.Recent FindingsAlthough patch testing may have low sensitivity, specificity is generally high with good utility depending on reaction phenotype and implicated medication. Patch testing has the highest sensitivity for acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms and at the site of fixed drug eruptions. It has the lowest sensitivity in Stevens-Johnson/toxic epidermal necrolysis.SummaryPatch testing, used in conjunction with clinical history, can help to improve identification of the culprit medication depending on reaction phenotype. Overall, it is safe to perform patch testing with rare risk of reactivation of primary reaction.
引用
收藏
页码:260 / 268
页数:9
相关论文
共 50 条
  • [21] Patch testing for cutaneous adverse drug reactions in a paediatric population: A retrospective review
    Costa Carvalho, Joni
    Alen Coutinho, Iolanda
    Matos, Ana Luisa
    Alves, Pedro
    Ramos, Leonor
    Goncalo, Margarida
    CONTACT DERMATITIS, 2022, 87 (04) : 373 - 376
  • [22] Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions
    Barbaud, Annick
    Romano, Antonino
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (02) : 307 - 322
  • [23] ELISpot assay as a diagnostic tool in drug hypersensitivity reactions
    Porebski, Grzegorz
    Piotrowicz-Wojcik, Katarzyna
    Spiewak, Radoslaw
    JOURNAL OF IMMUNOLOGICAL METHODS, 2021, 495
  • [24] Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management
    Iris M. Otani
    Aleena Banerji
    Current Allergy and Asthma Reports, 2016, 16
  • [25] Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions
    Boehm, Ruwen
    Cascorbi, Ingolf
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [26] Hypersensitivity drug reactions
    Thong, Bernard Y.
    Blanca, Miguel
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 14 (04) : 269 - 270
  • [27] Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group
    Scherer, K.
    Brockow, K.
    Aberer, W.
    Gooi, J. H. C.
    Demoly, P.
    Romano, A.
    Schnyder, B.
    Whitaker, P.
    Cernadas, J. S. R.
    Bircher, A. J.
    ALLERGY, 2013, 68 (07) : 844 - 852
  • [28] Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
    Chu, Mu-Tzu
    Chang, Wan-Chun
    Pao, Shih-Cheng
    Hung, Shuen-Iu
    BIOMEDICINES, 2023, 11 (01)
  • [29] Immediate and Delayed Hypersensitivity Reactions to Corticosteroids: Evaluation and Management
    Iris M. Otani
    Aleena Banerji
    Current Allergy and Asthma Reports, 2016, 16
  • [30] Immediate and Delayed Hypersensitivity Reactions to Corticosteroids: Evaluation and Management
    Otani, Iris M.
    Banerji, Aleena
    CURRENT ALLERGY AND ASTHMA REPORTS, 2016, 16 (03)